Patents by Inventor Jeroen Alexander Kortekaas

Jeroen Alexander Kortekaas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bunyaviruses with segmented glycoprotein precursor genes and methods for generating these viruses
    Patent number: 9750798
    Abstract: The invention relates to a bunyavirus, in which separated (NSm)Gn and Gc coding regions are functionally present on two different genome segments, preferably a bunyavirus that comprises a total of at least 4 genome segments. The invention further relates to methods for producing said bunyavirus, and to a composition comprising said bunyavirus and a suitable excipient.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: September 5, 2017
    Assignee: STICHTING WAGENINGEN RESEARCH
    Inventors: Jeroen Alexander Kortekaas, Paulus-Jozef Wichgers Schreur, Nadia Dimitrova Oreshkova, Robertus Jacobus Maria Moormann
  • Methods to produce bunyavirus replicon particles
    Patent number: 9657278
    Abstract: The invention relates to methods of producing infectious bunyavirus replicon particles. These bunyavirus replicon particles are safe and can be used outside a biosafety containment. The invention further relates to recombinant bunyavirus replicon particles and uses of these recombinant bunyavirus replicon particles.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: May 23, 2017
    Assignee: Stichting Dienst Landbouwkundig Onderzoek
    Inventors: Jeroen Alexander Kortekaas, Robertus Jacobus Maria Moormann
  • BUNYAVIRUSES WITH SEGMENTED GLYCOPROTEIN PRECURSOR GENES AND METHODS FOR GENERATING THESE VIRUSES
    Publication number: 20160271241
    Abstract: The invention relates to a bunyavirus, in which separated (NSm)Gn and Gc coding regions are functionally present on two different genome segments, preferably a bunyavirus that comprises a total of at least 4 genome segments. The invention further relates to methods for producing said bunyavirus, and to a composition comprising said bunyavirus and a suitable excipient.
    Type: Application
    Filed: May 21, 2014
    Publication date: September 22, 2016
    Applicant: Stichting Dienst Landbouwkundig Onderzoek
    Inventors: Jeroen Alexander Kortekaas, Paulus-Jozef Wichgers Schreur, Nadia Dimitrova Oreshkova, Robertus Jacobus Maria Moormann
  • METHODS TO PRODUCE BUNYAVIRUS REPLICON PARTICLES
    Publication number: 20160002608
    Abstract: The invention relates to methods of producing infectious bunyavirus replicon particles. These bunyavirus replicon particles are safe and can be used outside a biosafety containment. The invention further relates to recombinant bunyavirus replicon particles and uses of these recombinant bunyavirus replicon particles.
    Type: Application
    Filed: July 10, 2015
    Publication date: January 7, 2016
    Inventors: Jeroen Alexander Kortekaas, Robertus Jacobus Maria Moormann
  • Methods to produce bunyavirus replicon particles
    Patent number: 9109199
    Abstract: The invention relates to methods of producing infectious bunyavirus replicon particles. These bunyavirus replicon particles are safe and can be used outside a biosafety containment. The invention further relates to recombinant bunyavirus replicon particles and uses of these recombinant bunyavirus replicon particles.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: August 18, 2015
    Assignee: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK
    Inventors: Jeroen Alexander Kortekaas, Robertus Jacobus Maria Moormann
  • Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV
    Patent number: 8911744
    Abstract: The invention relates to a recombinant classical swine fever virus (CSFV). A preferred recombinant CSFV comprises a deletion of at least one amino acid in a “TAVSPTTLR” domain of the E2 protein. The invention further relates to a vaccine comprising the recombinant CSFV, a method for generating a recombinant CSFV, and use of a recombinant CSFV.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: December 16, 2014
    Assignee: Intervet International B.V.
    Inventors: Jeroen Alexander Kortekaas, Rianka Petronella Maria Vloet
  • METHODS TO PRODUCE BUNYAVIRUS REPLICON PARTICLES
    Publication number: 20130236493
    Abstract: The invention relates to methods of producing infectious bunyavirus replicon particles. These bunyavirus replicon particles are safe and can be used outside a biosafety containment. The invention further relates to recombinant bunyavirus replicon particles and uses of these recombinant bunyavirus replicon particles.
    Type: Application
    Filed: September 20, 2011
    Publication date: September 12, 2013
    Applicant: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK
    Inventors: Jeroen Alexander Kortekaas, Robertus Jacobus Maria Moormann
  • USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS
    Publication number: 20120276139
    Abstract: The invention relates to methods of stimulating an immune response against an antigenic protein in a mammalian subject. More specifically, the invention relates to routes of administration of a hybrid Newcastle Disease Virus-vector (NDV-vector) for eliciting an immune response against an antigenic protein that is encoded by the hybrid NDV-vector.
    Type: Application
    Filed: November 16, 2010
    Publication date: November 1, 2012
    Applicant: Stichting Dienst Landbouwkundig Onderzoek
    Inventors: Robertus Jacobus Maria Moormann, Jeroen Alexander Kortekaas, Adrianus Franciscus Gerardus Antonis, Bernardus Petrus Hubertus Peeters, Aldo Dekker
  • RECOMBINANT CLASSICAL SWINE FEVER VIRUS (CSFV) COMPRISING A MODIFIED E2 PROTEIN AND METHODS FOR GENERATING SAID RECOMBINANT CSFV
    Publication number: 20110287044
    Abstract: The invention relates to a recombinant classical swine fever virus (CSFV). A preferred recombinant CSFV comprises a deletion of at least one amino acid in a “TAVSPTTLR” domain of the E2 protein. The invention further relates to a vaccine comprising the recombinant CSFV, a method for generating a recombinant CSFV, and use of a recombinant CSFV.
    Type: Application
    Filed: December 23, 2009
    Publication date: November 24, 2011
    Inventors: Jeroen Alexander Kortekaas, Rianka Petronella Maria Vloet